companydata.dkZelandia Life Science R&D Consulting ApS: Financial statements 2020
CVR: 40206051
Zelandia Life Science R&D Consulting ApS (CVR 40206051) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 307,419 and a net result of DKK 236,162 compared with DKK 636,287 the year before. That is a decrease of 62.3% compared with the year before. Equity amounted to DKK 322,449. The solvency ratio was 77.4%.
- Gross Profit
- 307,419 kr.
- Profit/Loss
- 236,162 kr.
- Equity
- 322,449 kr.
- Total Assets
- 416,619 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 307 t. | 236 t. | 322 t. | - |
| 2019 | - | 815 t. | 636 t. | 686 t. | - |
How creditworthy is Zelandia Life Science R&D Consulting ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Zelandia Life Science R&D Consulting ApS has published its annual report for 2019. Gross profit came to DKK 814,925, and the net result was DKK 636,287.
As of February 25, 2020, KTHolding ApS is registered as an owner of Zelandia Life Science R&D Consulting ApS with an ownership share of 100%.
About Zelandia Life Science R&D Consulting ApS
Zelandia Life Science R&D Consulting ApS is a Danish company of the type Anpartsselskab based in Farum, founded in 2019. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Kristian Tage Hansen. The company is owned by KTHolding ApS. In 2025, the company reported a gross profit of DKK -72,481 and a net result of DKK -20,391 compared with DKK 670,851 the year before. Equity amounted to DKK 1,290,580.